NASDAQ:GNMK
Delisted
GenMark Diagnostics Stock News
$24.04
+0 (+0%)
At Close: May 27, 2022
Coronavirus Test Kits Market in North America 2020-2024, Segmented by Government and Non-Government End Users - ResearchAndMarkets.com
12:00am, Thursday, 21'st May 2020
The
Will GenMark Diagnostics' Stock Keep Rising?
03:16pm, Thursday, 14'th May 2020
Investors in the San Diego-based developer of diagnostic tests and equipment have seen their shares soar 149% since the start of 2020. While many companies have reduced or withdrawn 2020 financial gu
The aggregate gross proceeds to GenMark, before deducting underwriting discounts and commissions and other estimated offering expenses, were approximately $80.5 million. Cowen and William Blair acted
Top Ranked Momentum Stocks to Buy for May 8th
02:52pm, Friday, 08'th May 2020
Top Ranked Momentum Stocks to Buy for May 8th
GenMark shares are trading higher. The company reported a common stock offering of 7.2 million shares at $9.65 per share.
03:22pm, Thursday, 07'th May 2020Top Ranked Momentum Stocks to Buy for May 7th
02:41pm, Thursday, 07'th May 2020
Top Ranked Momentum Stocks to Buy for May 7th
GenMark Diagnostics: P/E Ratio Insights
02:39pm, Thursday, 07'th May 2020
In the current session, GenMark Diagnostics Inc. (NASDAQ: GNMK) is trading at $12.08, after a 24.4% spike. Over the past month, the stock increased by 97.21%, and in the past year, by 60.13%. With per
GenMark Prices 7.2M Share Public Offering of Common Stock @$9.65/Share
09:36am, Thursday, 07'th May 2020BRIEF-Genmark Prices Public Offering Of Common Stock
07:54am, Thursday, 07'th May 2020
* GENMARK DIAGNOSTICS INC - PRICING OF PREVIOUSLY ANNOUNCED UNDERWRITTEN PUBLIC OFFERING OF 7.3 MILLION SHARES OF COMMON STOCK AT PRICE OF $9.65 PER SHARE Source text for Eikon: Further company covera
GenMark Prices Public Offering of Common Stock
04:03am, Thursday, 07'th May 2020
CARLSBAD, May 06, 2020 (GLOBE NEWSWIRE via COMTEX) --
CARLSBAD, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) ("GenMark"...
GenMark Prices Public Offering of Common Stock
02:59am, Thursday, 07'th May 2020
The gross proceeds to GenMark, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $70.0 million. GenMark has granted the und
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
BRIEF-Genmark Commences Public Offering Of Common Stock
10:52pm, Wednesday, 06'th May 2020
* GENMARK COMMENCES PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage:
